Skip to main content
Log in

Reverse translational analysis of clinically reported, lamotrigine-induced cardiovascular adverse events using the halothane-anesthetized dogs

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Lamotrigine has been used for patients with epilepsy and/or bipolar disorder, overdose of which induced the hypotension, elevation of the atrial pacing threshold, cardiac conduction delay, wide complex tachycardia, cardiac arrest and Brugada-like electrocardiographic pattern. To clarify how lamotrigine induces those cardiovascular adverse events, we simultaneously assessed its cardiohemodynamic and electrophysiological effects using the halothane-anesthetized dogs (n = 4). Lamotrigine was intravenously administered in doses of 0.1, 1 and 10 mg/kg/10 min under the monitoring of cardiovascular variables, possibly providing subtherapeutic to supratherapeutic plasma concentrations. The low or middle dose of lamotrigine did not alter any of the variables. The high dose significantly delayed the intra-atrial and intra-ventricular conductions in addition to the prolongation of ventricular effective refractory period, whereas no significant change was detected in the other variables. Lamotrigine by itself has relatively wide safety margin for cardiohemodynamics, indicating that clinically reported hypotension may not be induced through its direct action on the resistance arterioles or capacitance venules. The electrophysiological effects suggested that lamotrigine can inhibit Na+ channel in the in situ hearts. This finding may partly explain the onset mechanism of lamotrigine-associated cardiac adverse events in the clinical cases. In addition, elevation of J wave was induced in half of the animals, suggesting that lamotrigine may have some potential to unmask Brugada electrocardiographic genotype in susceptible patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Alyahya B, Friesen M, Nauche B, Laliberté M (2018) Acute lamotrigine overdose: a systematic review of published adult and pediatric cases. Clin Toxicol 56:81–89

    Article  CAS  Google Scholar 

  2. Irifune R, Matsuda M, Tagaya M, Hara K, Tamura R (2017) Marked elevation of the atrial pacing threshold in a patient with sinus dysfunction on lamotrigine therapy. Open J Clin Med Case Rep 3:1299

    Google Scholar 

  3. Strimel WJ, Woodruff A, Cheung P, Kirmani BF, Stephen Huang SK (2010) Brugada-like electrocardiographic pattern induced by lamotrigine toxicity. Clin Neuropharmacol 33:265–267

    Article  Google Scholar 

  4. Rodrigues R, Amador P, Rassi L, Seixo F, Parreira L, Fonseca N, Soares L (2013) Brugada pattern in a patient medicated with lamotrigine (article in Portuguese; title and abstract were also provided in English). Rev Port Cardiol 32:807–810

    Article  Google Scholar 

  5. Leong KMW, Seligman H, Varnava AM (2017) Proarrhythmogenic effects of lamotrigine during ajmaline testing for Brugada syndrome. HeartRhythm Case Rep 3:167–171

    Article  Google Scholar 

  6. Lang DG, Wang CM, Cooper BR (1993) Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther 266:829–835

    CAS  PubMed  Google Scholar 

  7. Xie X, Lancaster B, Peakman T, Garthwaite J (1995) Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurons. Pflügers Arch 430:437–446

    Article  CAS  Google Scholar 

  8. Zona C, Avoli M (1997) Lamotrigine reduces voltage-gated sodium currents in rat central neurons in culture. Epilepsia 38:522–525

    Article  CAS  Google Scholar 

  9. Hainsworth AH, McNaughton NCL, Pereverzev A, Schneider T, Randall A (2003) Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents. Eur J Pharmacol 467:77–80

    Article  CAS  Google Scholar 

  10. Polak S, Wisniowska B, Brandys J (2009) Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs’ cardiotoxic properties. J Appl Toxicol 29:183–206

    Article  CAS  Google Scholar 

  11. Sugiyama A (2008) Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. Br J Pharmacol 154:1528–1537

    Article  CAS  Google Scholar 

  12. Haïssaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L, Pasquié JL, Nogami A, Babuty D, Yli-Mayry S, De Chillou C, Scanu P, Mabo P, Matsuo S, Probst V, Le Scouarnec S, Defaye P, Schlaepfer J, Rostock T, Lacroix D, Lamaison D, Lavergne T, Aizawa Y, Englund A, Anselme F, O’Neill M, Hocini M, Lim KT, Knecht S, Veenhuyzen GD, Bordachar P, Chauvin M, Jais P, Coureau G, Chene G, Klein GJ, Clémenty J (2008) Sudden cardiac arrest associated with early repolarization. N Engl J Med 358:2016–2023

    Article  Google Scholar 

  13. Yamazaki-Hashimoto Y, Nakamura Y, Ohara H, Cao X, Kitahara K, Izumi-Nakaseko H, Ando K, Yamazaki H, Ikeda T, Yamazaki J, Sugiyama A (2015) Fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations. J Toxicol Sci 40:33–42

    Article  CAS  Google Scholar 

  14. Van de Water A, Verheyen J, Xhonneux R, Reneman RS (1989) An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods 22:207–217

    Article  Google Scholar 

  15. Sugiyama A, Hashimoto K (1998) Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring. Toxicol Appl Pharmacol 152:261–269

    Article  CAS  Google Scholar 

  16. Takahara A, Wagatsuma H, Aritomi S, Konda T, Akie Y, Nakamura Y, Sugiyama A (2011) Measurements of cardiac ion channel subunits in the chronic atrioventricular block dog. J Pharmacol Sci 116:132–135

    Article  CAS  Google Scholar 

  17. Ishizue N, Niwano S, Saito M, Fukaya H, Nakamura H, Igarashi T, Fujiishi T, Yoshizawa T, Oikawa J, Satoh A, Kishihara J, Murakami M, Niwano H, Miyaoka H, Ako J (2016) Polytherapy with sodium channel-blocking antiepileptic drugs is associated with arrhythmogenic ST-T abnormality in patients with epilepsy. Seizure 40:81–87

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported in part by JSPS KAKENHI (Grant Numbers 19K16505 and 20K16136). The authors thank Mrs. Yuri Ichikawa for her technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Atsushi Sugiyama.

Ethics declarations

Conflict of interest

The authors indicated no potential conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goto, A., Hagiwara-Nagasawa, M., Kambayashi, R. et al. Reverse translational analysis of clinically reported, lamotrigine-induced cardiovascular adverse events using the halothane-anesthetized dogs. Heart Vessels 36, 424–429 (2021). https://doi.org/10.1007/s00380-020-01716-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-020-01716-8

Keywords

Navigation